Cochrane Abstracts
Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome: Cochrane systematic review
Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Recombinant FSH Versus Urinary Gonadotrophins or Recombinant FSH for Ovulation Induction in Subfertility Associated With Polycystic Ovary Syndrome: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434606/1/Recombinant_FSH_versus_urinary_gonadotrophins_or_recombinant_FSH_for_ovulation_induction_in_subfertility_associated_with_polycystic_ovary_syndrome:_Cochrane_systematic_review. Accessed 20 January 2021.
Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434606/1/Recombinant_FSH_versus_urinary_gonadotrophins_or_recombinant_FSH_for_ovulation_induction_in_subfertility_associated_with_polycystic_ovary_syndrome:_Cochrane_systematic_review. Accessed January 20, 2021.
Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome: Cochrane systematic review. In Cochrane Abstracts Retrieved January 20, 2021, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/434606/1/Recombinant_FSH_versus_urinary_gonadotrophins_or_recombinant_FSH_for_ovulation_induction_in_subfertility_associated_with_polycystic_ovary_syndrome:_Cochrane_systematic_review
Recombinant FSH Versus Urinary Gonadotrophins or Recombinant FSH for Ovulation Induction in Subfertility Associated With Polycystic Ovary Syndrome: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 January 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434606/1/Recombinant_FSH_versus_urinary_gonadotrophins_or_recombinant_FSH_for_ovulation_induction_in_subfertility_associated_with_polycystic_ovary_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant FSH versus urinary gonadotrophins or recombinant FSH for ovulation induction in subfertility associated with polycystic ovary syndrome: Cochrane systematic review
ID - 434606
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434606/1/Recombinant_FSH_versus_urinary_gonadotrophins_or_recombinant_FSH_for_ovulation_induction_in_subfertility_associated_with_polycystic_ovary_syndrome:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
